GSK3B and neoplasm: Likewise, the inhibition of catabolic pathways (IL-6, TNF-alpha), balanced with the stimulation of anabolic pathways (FoxO3a, p-AKT, p-mTOR, and P-GSK-3β), has occurred in the counteraction of tumor-induced cachexia [56].